How a new antibiotic destroys extremely drug-resistant tuberculosis | Ars Technica
https://arstechnica.com/science/2019/08/how-a-new-antibiotic-destroys-extremely-drug-resistant-tuberculosis/
Keith S. Kaye, MD, MPH: RESTORE-IMI 2 and Treating Critically Ill Patients With Respiratory Infections
https://www.contagionlive.com/news/keith-s-kaye-md-mph-restoreimi-2-and-treating-critically-ill-patients-with-respiratory-infections
AcinetobacterAmikacinAmpC cephalosporinaseBacteremiaBacterial pneumoniaCefepimeCiprofloxacinEnterobacteriaceaeExtended spectrum beta-lactamases (ESBL)GentamicinImipenemImipenem-cilastatin-relebactamKlebsiella pneumoniae carbapenemase (KPC)LevofloxacinLinezolidMeropenemPiperacillin-tazobactamPseudomonasRelebactamSepsisTobramycinVancomycin
The pitfall of cohort isolation in an outbreak of linezolid-resistant, vancomycin-resistant enterococci - PubMed
https://pubmed.ncbi.nlm.nih.gov/31449869/